A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Clinical trial NCT05262400 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05262400
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Solid Tumors

Start date: 2022-03-14
Primary completion: 2026-08-23
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.